The regulatory approaches used to approve Covid-19 vaccines vary substantially across different countries. While some states assign responsibility for vaccine approval to independent regulatory agencies, politicians in other states have greater scope to influence decision-making. Eva Heims and Slobodan Tomic write that the current push to roll out vaccination programmes as quickly as possible is shining a light on competition between these independent and politicised models of regulation
